Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate, as well as para toluene sulphonyl hydrazide and benzene sulphonic acid and sodium salt; and benzyl nicotinate, bisphenol C, bisphenol C(chloride), ethyl nicotinate, ethyl para toluene sulphonate, and N-methyl imidazole. In addition, the company's products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Further, it offers contract manufacturing services. The company was incorporated in 1984 and is headquartered in Mumbai, India.
Aarti Drugs Dividend Announcement
• Aarti Drugs announced a annually dividend of ₹1.00 per ordinary share which will be made payable on 2024-02-23. Ex dividend date: 2024-02-06
• Aarti Drugs annual dividend for 2024 was ₹1.00
• Aarti Drugs annual dividend for 2023 was ₹1.00
• Aarti Drugs's trailing twelve-month (TTM) dividend yield is 0.22%
Aarti Drugs Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-02-06 | ₹1.00 | annually | 2024-02-23 |
2023-02-08 | ₹1.00 | annually | 2023-02-26 |
2022-02-09 | ₹1.00 | annually | 2022-03-02 |
2020-11-03 | ₹2.50 | annually | 2020-11-22 |
2020-02-17 | ₹2.00 | annually | 2020-03-07 |
2019-07-26 | ₹1.00 | annually | 2019-08-12 |
2018-08-01 | ₹1.00 | annually | 2018-09-07 |
2017-08-09 | ₹1.00 | annually | 2017-09-15 |
2016-03-22 | ₹3.00 | annually | 2016-03-31 |
2016-02-12 | ₹1.50 | annually | 2016-02-22 |
2015-11-10 | ₹2.25 | annually | 2015-11-20 |
2015-08-05 | ₹3.00 | annually | 2015-08-22 |
2015-02-04 | ₹5.00 | annually | 2015-02-10 |
2014-11-19 | ₹5.00 | annually | 2014-11-27 |
2014-07-02 | ₹5.50 | annually | 2014-07-19 |
2014-02-05 | ₹4.50 | annually | 2014-03-02 |
2013-11-19 | ₹3.00 | annually | 2013-11-25 |
2013-07-24 | ₹4.00 | annually | 2013-08-09 |
2013-02-11 | ₹3.00 | annually | 2013-02-16 |
2012-11-05 | ₹3.00 | annually | 2012-11-10 |
2012-08-17 | ₹3.00 | annually | 2012-09-05 |
2012-02-06 | ₹2.00 | annually | 2012-02-10 |
Aarti Drugs Dividend per year
Aarti Drugs Dividend growth
Aarti Drugs Dividend Yield
Aarti Drugs current trailing twelve-month (TTM) dividend yield is 0.22%. Interested in purchasing Aarti Drugs stock? Use our calculator to estimate your expected dividend yield:
Aarti Drugs Financial Ratios
Aarti Drugs Dividend FAQ
Other factors to consider when evaluating Aarti Drugs as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Aarti Drugs stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Aarti Drugs's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Aarti Drugs publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Aarti Drugs distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Aarti Drugs are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Aarti Drugs sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Aarti Drugs distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Aarti Drugs declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Aarti Drugs's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Aarti Drugs's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.